Page 4 of Biocon

Biocon, Biocon Q2 results, profit, revenue, EBITDA, Biosimilars, Biocon Generics, Biocon Biologics, Syngene, Kiran Mazumdar-Shaw

Biocon Q1 profit drops 29.8% to Rs 101.40 crore, revenue up 60% on jump in Biosimilars revenue

Biocon posted revenue from operations at Rs 3422.60 crore, up 60 per cent as against Rs 2139.50 crore.

August 11, 2023 09:13 IST

Who is Siddharth Mittal: The CEO of Biocon, founded by Kiran Mazumdar Shaw; know about his career, education, and net worth

Biocon consolidated financial revenue for the fourth quarter and the fiscal year ended on March 31, 2023 with Rs 3,929…

August 7, 2023 08:00 IST

Biocon Biologics’ biosimilar of Humira is now available in United States

Biocon Biologics, which recently announced its acquisition of Viatris’ global biosimilars business, has secured multiple biosimilar approvals in the U.S.,…

July 4, 2023 11:37 IST

Biocon Q4FY23 profit up 31.3% at Rs 313.20 crore on robust sales, beats estimates

Biocon posted revenue from operations at Rs 3773.90 crore, up 56.7 per cent in comparison to Rs 2408.80 crore in…

May 24, 2023 13:22 IST

Biocon Biologics, biosimilars, healthcare news, pharma news,

Biocon Biologics’ new monoclonal antibodies manufacturing facility receives EU GMP certification for cancer biosimilar

Last year, the same facility was approved for biosimilar Trastuzumab which is a targeted cancer drug and is also known…

April 28, 2023 18:12 IST

Serum Institute to pump in additional $150 million in Biocon Biologics

With the fresh capital infusion, Serum’s total investment in Biocon Biologics will touch USD 300 million.

Updated: April 25, 2023 15:53 IST

Biocon, Biocon Biologics, bioprocessing awards, healthcare news,

Biocon Biologics Wins ‘ABEA : Bioprocessing Excellence in South Asia’ Award

According to its statement, Biocon Biologics was recognized as the winner as it garnered the maximum number of votes from…

March 29, 2023 14:00 IST

Top female entrepreneurs, women entrepreneurs, richest women entrepreneurs, women billionaire entrepreneurs, Kiran Mazumdar-Shaw, Smita Crishna-Godrej, JIndal, lifestyle

Meet 6 richest women in India, know about their net worth and how they make their crores

Here’s a list of the richest women in India with massive net worth. Take a look:

Updated: March 8, 2023 14:03 IST

Biocon reports dip in PAT 25 percent yoy; Revenue up 36 percent to Rs. 3,020 Crore in Q3FY23

According to Shaw, the biggest contribution came from the Biosimilars business, which reported a 54% increase in revenues to Rs…

February 14, 2023 20:51 IST

Biocon Biologics appoints Shreehas Tambe as Managing Director and CEO

According to the company, Shreehas Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.

December 5, 2022 14:24 IST

Adani Enterprises, Keystone Realtors, M&M Financial, Biocon, PVR, Can Fin Homes stocks in focus on F&O expiry

Indian benchmark indices are likely to open higher on F&O expiry amid firm global cues. SGX Nifty hinted at a…

November 24, 2022 07:12 IST

Biocon’s net profit declines 10% to Rs 168 crore in Q2FY23; Revenue up 26%

The strategic alliance with Serum Institute Life Sciences (SILS) for vaccines is on track for closure by Q3FY22, the company…

November 14, 2022 22:44 IST

Devastated to lose my husband, says Biocon founder Kiran Mazumdar-Shaw

John Shaw, who had served the Bengaluru-headquartered biopharmaceutical company as the Vice-Chairman and Non-Executive Director for over 22 years, passed…

Updated: October 25, 2022 13:30 IST

kiran shaw, kiran shaw husband, kiran mazumdar shaw husband, biocon ceo, biocon, john shaw, john shaw husband

‘John Shaw loved India, his passing a huge loss,’ say friends

To those who have seen the couple from outside, John Shaw seemed a pillar of support for Kiran Mazumdar in…

Updated: October 26, 2022 08:04 IST

Biocon Biologics, Biosimilars, Yoshindo Inc, Ustekinumab, bUstekinumab, health news, pharma news,

Biocon Biologics inks out-licensing agreement with Yoshindo Inc; To commercialise biosimilars in Japan

Reportedly, Biocon Biologics became the first company from India to commercialize a biosimilar in Japan, after its Insulin Glargine was…

October 17, 2022 10:57 IST

kiran shaw, biocon, jobs, education in india, yuva unstoppable

Never let gender come in the way of your ambitions, dream big: Kiran Mazumdar-Shaw at Yuva Unstoppable event

Shaw also emphasised on the importance of cleanliness and how it is a factor that will determine our country’s future…

Updated: October 3, 2022 16:35 IST

CBI files chargesheet in Biocon bribery case against five people

The bribe was allegedly for favourably recommending the file of Insulin Aspart Injection to the Subject Expert Committee (SEC) meeting…

August 25, 2022 17:07 IST

In view of this conclusion, the SAT quashed and set aside the Sebi order which had held Tambe guilty of insider trading and the corresponding penalty. The penalty of Rs 1 lakh for delayed disclosure under regulation 7(2)(a) was upheld.

SAT quashes insider trading charges against Biocon’s Shreehas Tambe

The appellant was also penalised for a sum of Rs 2 lakh.

August 4, 2022 00:10 IST

Related News

EB-5 fees, EB-5 filing fees cut, EB-5 visa, USCIS EB-5 rule, DHS EB-5 rule, Form I-526 fee reduction, Form I-829 petition, EB-5 investor program, EB-5 technology fee, EB-5 program changes

US cuts EB-5 fees for foreign investors seeking employment-based green cards

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar link and KYC rules explained

Aadhaar card update new rules from November 2025: You won’t need to upload documents anymore — here’s how to change your details online

Four big companies have now stopped sponsoring H-1B visas. Here is the full list

From H-1B to green card: Follow the journey of an Indian entrepreneur to $3.7 billion

Indian techie overcomes H-1B challenges, gets green card, quits job, and achieves $3.7 billion success

F-1 visa denied for applicant after single question at US Consulate

Jio pivoting from mobile growth to home broadband play: Analysts

Business3 hr ago

Reliance Jio’s Q2 results showed a shift towards home connectivity, with 8.3 million new users and a total of 506 million subscribers. Fixed broadband and 5G net additions were at 2.4 million and 21 million respectively. FWA and FTTH net adds were 2.1 million and 0.9 million, indicating the success of Jio’s home broadband expansion.

View all shorts